Filing Details
- Accession Number:
- 0001104659-21-061899
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-05 13:00:00
- Reporting Period:
- 2021-05-03
- Accepted Time:
- 2021-05-05 20:30:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1192448 | Glaukos Corp | GKOS | Surgical & Medical Instruments & Apparatus (3841) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1705850 | E Joseph Gilliam | C/O Glaukos Corporation, 229 Avenida Fabricante San Clemente CA 92672 | Cfo, Svp Corporate Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-05-03 | 10,000 | $41.69 | 67,739 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-05-03 | 5,000 | $30.92 | 72,739 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-05-03 | 13,992 | $93.18 | 58,747 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-03 | 5,258 | $94.26 | 53,489 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-05-03 | 750 | $95.02 | 52,739 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-05-03 | 10,000 | $0.00 | 10,000 | $41.69 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-05-03 | 5,000 | $0.00 | 5,000 | $30.92 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 139,343 | 2027-05-05 | No | 4 | M | Direct | |
| 28,437 | 2028-03-14 | No | 4 | M | Direct |
Footnotes
- Includes 35,517 restricted stock units that have not yet vested or been delivered to the Reporting Person.
- These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices.
- This transaction was executed in multiple trades at prices ranging from $92.78 to $93.74. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $93.81 to $94.80. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $94.93 to $95.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- These options vest over four years from the grant date, with 25% vesting on the first anniversary of the grant date and the remaining amount vesting in equal monthly installments over the following three years.
Billionaire Hedge Funds
